Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Rogerio Serafim Parra"'
Autor:
Natália Sousa Freitas QUEIROZ, Fábio Vieira TEIXEIRA, Rogerio Serafim PARRA, Paulo Gustavo KOTZE
Publikováno v:
Arquivos de Gastroenterologia, Vol 57, Iss 4, Pp 507-510 (2020)
ABSTRACT Therapeutic drug monitoring (TDM) of infliximab (IFX) has been recognized as an important strategy in the management of secondary loss of response to this agent, guiding clinical decision-making in the management of inflammatory bowel diseas
Externí odkaz:
https://doaj.org/article/cc59790523ee4a7d94af939fb3d250c6
Autor:
Barbara Bianca Linhares Mota, Juliana Lima Toledo, Karina Kendra Mar Marques, Marley Ribeiro Feitosa, Rogerio Serafim Parra, José Joaquim Ribeiro da Rocha, Omar Feres
Publikováno v:
Journal of Coloproctology, Vol 37, Iss , Pp 119- (2017)
Externí odkaz:
https://doaj.org/article/7c145985c1fb4e4088ba94ac2f67263c
Autor:
Josiane Harumi Cihoda Lopes, Fernanda Costa Pereira, Rodrigo Saad Rodrigues, Marley Ribeiro Feitosa, Rogerio Serafim Parra, Omar Feres, Jose Joaquim Ribeiro da Rocha
Publikováno v:
Journal of Coloproctology, Vol 37, Iss , Pp 117- (2017)
Externí odkaz:
https://doaj.org/article/38f79032698f435785dee116691aab8e
Autor:
Leonardo Estenio Iezzi, Marley Ribeiro Feitosa, Bruno Amaral Medeiros, Jussara C. Aquino, Ana Luiza Normanha Ribeiro de Almeida, Rogerio Serafim Parra, José Joaquim Ribeiro da Rocha, Omar Féres
Publikováno v:
Acta Cirúrgica Brasileira, Vol 26, Pp 129-132 (2011)
PURPOSE: Evaluate the application of Hyperbaric Oxygen Therapy (HBO) in patients with Crohn's disease (CD) refractory to pharmacologic therapy, who developed abdominal, anorectal or skin complications. METHODS: Fourteen selected patients with refract
Externí odkaz:
https://doaj.org/article/88cd20a2bac445298c049deec2acdf8a
Autor:
Ana Elisa Moraes Righetti, Cristiane Jacomini, Rogerio Serafim Parra, Ana Luiza Normanha Ribeiro de Almeida, José Joaquim Ribeiro Rocha, Omar Féres
Publikováno v:
Clinics, Vol 66, Iss 10, Pp 1839-1842 (2011)
Externí odkaz:
https://doaj.org/article/29293c766fe345b1b6aa0a0cfc7743d6
Autor:
Rogerio Serafim Parra, Ana Luiza Normanha Ribeiro de Almeida, Giovana Bachega Badiale, Margarida Maria Fernandes da Silva Moraes, José Joaquim Ribeiro Rocha, Omar Féres
Publikováno v:
Clinics, Vol 65, Iss 10, Pp 1063-1065 (2010)
Externí odkaz:
https://doaj.org/article/fc9a6103853a40ea89b91106bfeea321
Publikováno v:
Clinics, Vol 74
Externí odkaz:
https://doaj.org/article/75c8a3930a6d4aac89899095df5b2f65
Autor:
Rogerio Serafim Parra, Fernando Passador Valério, José Vitor Cabral Zanardi, Marley Ribeiro Feitosa, Omar Féres, José Joaquim Ribeiro da Rocha, Daniela França Camargo Freitas
Publikováno v:
70° Congresso Brasileiro de Coloproctologia.
Autor:
Leticia Rodrigues de Souza, Daniela Oliveira Magro, Claudio Saddy Rodrigues Coy, Eron Fábio Miranda, Rogerio Serafim Parra, Ligia Yukie Sassaki, Fabio Vieira Teixeira, Paulo Gustavo Kotze
Publikováno v:
70° Congresso Brasileiro de Coloproctologia.
Autor:
Rogerio Serafim Parra, Sandro da Costa Ferreira, Vanessa Foresto Machado, Cintia Maura Caseiro Nigro, José Joaquim Ribeiro da Rocha, Luiz Ernesto de Almeida Troncon, Omar Feres
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 7; Pages: 2672
Background and aims: Brazilian patients with inflammatory bowel diseases (IBD) requiring therapy with biological agents usually have access to medicines through the National Unified Health Care System (SUS). This study aimed to analyze Brazilian IBD